Hamburg: Resource Constraints Limit Compounding Inspection Push

FDA Commissioner Margaret Hamburg said the agency needs more money and authority to keep its recent spate of surprise compounding pharmacy inspections going, but GOP House leaders rejected the request during a confrontational committee hearing last week.

This article is viewable by subscribers only. To view this article, click  here